NF-κB through a signaling pathway can cause inhibition of human concentrative nucleoside transporter 1 and 3 and human equilibrative nucleoside transporters necessary for the uptake of gemcitabine into a tumor cell[30]. This evidence concerns the gene SLC28A1 and neoplasm.